{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:18:33Z","timestamp":1792001913614,"version":"4.4.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"crossref","award":["StG 4841"],"award-info":[{"award-number":["StG 4841"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"crossref","award":["IG 14455"],"award-info":[{"award-number":["IG 14455"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Epigen Flagship Project","award":["13\/05\/R\/42"],"award-info":[{"award-number":["13\/05\/R\/42"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12943-017-0655-2","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T01:41:29Z","timestamp":1494380489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation"],"prefix":"10.1186","volume":"16","author":[{"given":"Teresa","family":"Bellissimo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ganci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Tito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pulito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Masciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Diso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Anile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Petrozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Giangaspero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Pescarmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Facciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Venuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Blandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-7912","authenticated-orcid":false,"given":"Francesco","family":"Fazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,10]]},"reference":[{"key":"655_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11748-011-0814-0","volume":"60","author":"F Venuta","year":"2012","unstructured":"Venuta F, Rendina EA, Anile M, de Giacomo T, Vitolo D, Coloni GF. Thymoma and thymic carcinoma. Gen Thorac Cardiovasc Surg. 2012;60:1\u201312.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"655_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00737071","volume":"407","author":"M Marino","year":"1985","unstructured":"Marino M, Muller-Hermelink HK. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol. 1985;407:119\u201349.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"655_CR3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/JTO.0000000000000154","volume":"9","author":"A Marx","year":"2014","unstructured":"Marx A, Strobel P, Badve SS, Chalabreysse L, Chan JK, Chen G, de Leval L, Detterbeck F, Girard N, Huang J, et al. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol. 2014;9:596\u2013611.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"655_CR4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","volume":"2015","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to TheWorld Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol. 2015;2015(10):1240\u20132.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"655_CR5","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","volume":"2015","author":"A Marx","year":"2015","unstructured":"Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, Jaffe ES, Kurrer MO, Marom EM, Moreira AL, et al. The World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. J Thorac Oncol. 2015;2015(10):1383\u201395.","journal-title":"J Thorac Oncol"},{"key":"655_CR6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/JTO.0000000000000393","volume":"10","author":"CA Weis","year":"2015","unstructured":"Weis CA, Yao X, Deng Y, Detterbeck FC, Marino M, Nicholson AG, Huang J, Strobel P, Antonicelli A, Marx A. Contributors to the IRD: The impact of thymoma histotype on prognosis in a worldwide database. J Thorac Oncol. 2015;10:367\u201372.","journal-title":"J Thorac Oncol"},{"key":"655_CR7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.lungcan.2013.09.013","volume":"83","author":"PL Filosso","year":"2014","unstructured":"Filosso PL, Ruffini E, Lausi PO, Lucchi M, Oliaro A, Detterbeck F. Historical perspectives: The evolution of the thymic epithelial tumors staging system. Lung Cancer. 2014;83:126\u201332.","journal-title":"Lung Cancer"},{"key":"655_CR8","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/JTO.0000000000000290","volume":"9","author":"FC Detterbeck","year":"2014","unstructured":"Detterbeck FC, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Frazier AA, Giaccone G, Huang J, et al. The IASLC\/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014;9:S65\u201372.","journal-title":"J Thorac Oncol"},{"issue":"Suppl 2","key":"655_CR9","first-page":"S228","volume":"6","author":"E Ruffini","year":"2014","unstructured":"Ruffini E, Venuta F. Management of thymic tumors: a European perspective. J Thorac Dis. 2014;6 Suppl 2:S228\u2013237.","journal-title":"J Thorac Dis"},{"issue":"Suppl 5","key":"655_CR10","doi-asserted-by":"crossref","first-page":"v40","DOI":"10.1093\/annonc\/mdv277","volume":"26","author":"N Girard","year":"2015","unstructured":"Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S, Committee EG. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v40\u201355.","journal-title":"Ann Oncol"},{"key":"655_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fonc.2015.00267","volume":"5","author":"A Rajan","year":"2015","unstructured":"Rajan A, Wakelee H, Giaccone G. Novel Treatments for Thymoma and Thymic Carcinoma. Front Oncol. 2015;5:267.","journal-title":"Front Oncol"},{"key":"655_CR12","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/annonc\/mdu527","volume":"26","author":"D Serpico","year":"2015","unstructured":"Serpico D, Trama A, Haspinger ER, Agustoni F, Botta L, Berardi R, Palmieri G, Zucali P, Gallucci R, Broggini M, et al. Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors. Ann Oncol. 2015;26:838\u201347.","journal-title":"Ann Oncol"},{"key":"655_CR13","doi-asserted-by":"crossref","unstructured":"Alberobello AT, Wang Y, Beerkens FJ, Conforti F, McCutcheon JN, Rao G, Raffeld M, Liu J, Rahhal R, Zhang YW, Giaccone G. PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors. J Thorac Oncol. 2016;11:1345\u201356.","DOI":"10.1016\/j.jtho.2016.04.013"},{"key":"655_CR14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.lungcan.2016.04.024","volume":"97","author":"J Remon","year":"2016","unstructured":"Remon J, Girard N, Mazieres J, Dansin E, Pichon E, Grellier L, Dubos C, Lindsay CR, Besse B. Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network. Lung Cancer. 2016;97:99\u2013104.","journal-title":"Lung Cancer"},{"key":"655_CR15","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","volume":"29","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Petrini I, Rajan A, Wang Y, Giaccone G. Thymic malignancies: from clinical management to targeted therapies. J Clin Oncol. 2011;29:4820\u20137.","journal-title":"J Clin Oncol"},{"key":"655_CR16","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","volume":"15","author":"N Girard","year":"2009","unstructured":"Girard N, Shen R, Guo T, Zakowski MF, Heguy A, Riely GJ, Huang J, Lau C, Lash AE, Ladanyi M, et al. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res. 2009;15:6790\u20139.","journal-title":"Clin Cancer Res"},{"key":"655_CR17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00432-001-0319-9","volume":"128","author":"JD Henley","year":"2002","unstructured":"Henley JD, Koukoulis GK, Loehrer Sr PJ. Epidermal growth factor receptor expression in invasive thymoma. J Cancer Res Clin Oncol. 2002;128:167\u201370.","journal-title":"J Cancer Res Clin Oncol"},{"key":"655_CR18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2006.07.003","volume":"248","author":"M Meister","year":"2007","unstructured":"Meister M, Schirmacher P, Dienemann H, Mechtersheimer G, Schnabel PA, Kern MA, Herpel E, Xu EC, Muley T, Thomas M, Rieker RJ. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas. Cancer Lett. 2007;248:186\u201391.","journal-title":"Cancer Lett"},{"key":"655_CR19","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1097\/JTO.0b013e3181f209b9","volume":"5","author":"N Girard","year":"2010","unstructured":"Girard N. Thymic tumors: relevant molecular data in the clinic. J Thorac Oncol. 2010;5:S291\u2013295.","journal-title":"J Thorac Oncol"},{"key":"655_CR20","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1097\/JTO.0b013e3181f209a8","volume":"5","author":"P Strobel","year":"2010","unstructured":"Strobel P, Hohenberger P, Marx A. Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol. 2010;5:S286\u2013290.","journal-title":"J Thorac Oncol"},{"key":"655_CR21","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1093\/annonc\/mds147","volume":"23","author":"T Mimae","year":"2012","unstructured":"Mimae T, Tsuta K, Kondo T, Nitta H, Grogan TM, Okada M, Asamura H, Tsuda H. Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. Ann Oncol. 2012;23:3129\u201337.","journal-title":"Ann Oncol"},{"key":"655_CR22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.21037\/jtd.2016.02.40","volume":"8","author":"S Conti","year":"2016","unstructured":"Conti S, Gallo E, Sioletic S, Facciolo F, Palmieri G, Lauriola L, Evoli A, Martucci R, Di Benedetto A, Novelli F, et al. Molecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma. J Thorac Dis. 2016;8:386\u201395.","journal-title":"J Thorac Dis"},{"key":"655_CR23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/icvts\/ivv040","volume":"20","author":"B Hu","year":"2015","unstructured":"Hu B, Rong H, Han Y, Li Q. Do thymic malignancies respond to target therapies? Interact Cardiovasc Thorac Surg. 2015;20:855\u20139.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"655_CR24","first-page":"2202","volume":"5","author":"W Zhuo","year":"2015","unstructured":"Zhuo W, Zhang L, Zhu Y, Xie Q, Zhu B, Chen Z. Valproic acid, an inhibitor of class I histone deacetylases, reverses acquired Erlotinib-resistance of lung adenocarcinoma cells: a Connectivity Mapping analysis and an experimental study. Am J Cancer Res. 2015;5:2202\u201311.","journal-title":"Am J Cancer Res"},{"key":"655_CR25","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1158\/1078-0432.CCR-14-0968","volume":"20","author":"A Thomas","year":"2014","unstructured":"Thomas A, Rajan A, Szabo E, Tomita Y, Carter CA, Scepura B, Lopez-Chavez A, Lee MJ, Redon CE, Frosch A, et al. A phase I\/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study. Clin Cancer Res. 2014;20:5392\u2013402.","journal-title":"Clin Cancer Res"},{"key":"655_CR26","first-page":"169","volume":"2016","author":"J Liz","year":"1859","unstructured":"Liz J, Esteller M. lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 1859;2016:169\u201376.","journal-title":"Biochim Biophys Acta"},{"key":"655_CR27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrg3607","volume":"15","author":"T Chen","year":"2014","unstructured":"Chen T, Dent SY. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat Rev Genet. 2014;15:93\u2013106.","journal-title":"Nat Rev Genet"},{"key":"655_CR28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2012.06.008","volume":"22","author":"JS You","year":"2012","unstructured":"You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell. 2012;22:9\u201320.","journal-title":"Cancer Cell"},{"key":"655_CR29","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.mam.2012.06.005","volume":"34","author":"M Malumbres","year":"2013","unstructured":"Malumbres M. miRNAs and cancer: an epigenetics view. Mol Aspects Med. 2013;34:863\u201374.","journal-title":"Mol Aspects Med"},{"key":"655_CR30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nsmb1142","volume":"13","author":"DH Kim","year":"2006","unstructured":"Kim DH, Villeneuve LM, Morris KV, Rossi JJ. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol. 2006;13:793\u20137.","journal-title":"Nat Struct Mol Biol"},{"key":"655_CR31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2010.10.017","volume":"301","author":"C Chen","year":"2011","unstructured":"Chen C, Yin N, Yin B, Lu Q. DNA methylation in thoracic neoplasms. Cancer Lett. 2011;301:7\u201316.","journal-title":"Cancer Lett"},{"key":"655_CR32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.lungcan.2013.12.004","volume":"83","author":"M Mokhtar","year":"2014","unstructured":"Mokhtar M, Kondo K, Namura T, Ali AH, Fujita Y, Takai C, Takizawa H, Nakagawa Y, Toba H, Kajiura K, et al. Methylation and expression profiles of MGMT gene in thymic epithelial tumors. Lung Cancer. 2014;83:279\u201387.","journal-title":"Lung Cancer"},{"key":"655_CR33","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/JTO.0000000000000298","volume":"9","author":"A Rajan","year":"2014","unstructured":"Rajan A, Girard N, Marx A. State of the art of genetic alterations in thymic epithelial tumors. J Thorac Oncol. 2014;9:S131\u2013136.","journal-title":"J Thorac Oncol"},{"key":"655_CR34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/1471-2164-8-305","volume":"8","author":"GY Lee","year":"2007","unstructured":"Lee GY, Yang WI, Jeung HC, Kim SC, Seo MY, Park CH, Chung HC, Rha SY. Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization. BMC Genomics. 2007;8:305.","journal-title":"BMC Genomics"},{"key":"655_CR35","doi-asserted-by":"crossref","first-page":"e42669","DOI":"10.1371\/journal.pone.0042669","volume":"7","author":"S Badve","year":"2012","unstructured":"Badve S, Goswami C, Gokmen-Polar Y, Nelson Jr RP, Henley J, Miller N, Zaheer NA, Sledge Jr GW, Li L, Kesler KA, Loehrer Sr PJ. Molecular analysis of thymoma. PLoS One. 2012;7:e42669.","journal-title":"PLoS One"},{"key":"655_CR36","doi-asserted-by":"crossref","first-page":"e60572","DOI":"10.1371\/journal.pone.0060572","volume":"8","author":"I Petrini","year":"2013","unstructured":"Petrini I, Rajan A, Pham T, Voeller D, Davis S, Gao J, Wang Y, Giaccone G. Whole genome and transcriptome sequencing of a b3 thymoma. PLoS One. 2013;8:e60572.","journal-title":"PLoS One"},{"key":"655_CR37","doi-asserted-by":"crossref","first-page":"e66047","DOI":"10.1371\/journal.pone.0066047","volume":"8","author":"Y Gokmen-Polar","year":"2013","unstructured":"Gokmen-Polar Y, Cook RW, Goswami CP, Wilkinson J, Maetzold D, Stone JF, Oelschlager KM, Vladislav IT, Shirar KL, Kesler KA, et al. A gene signature to determine metastatic behavior in thymomas. PLoS One. 2013;8:e66047.","journal-title":"PLoS One"},{"key":"655_CR38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2008.07.015","volume":"64","author":"Y Hirose","year":"2009","unstructured":"Hirose Y, Kondo K, Takizawa H, Nagao T, Nakagawa Y, Fujino H, Toba H, Kenzaki K, Sakiyama S, Tangoku A. Aberrant methylation of tumour-related genes in thymic epithelial tumours. Lung Cancer. 2009;64:155\u20139.","journal-title":"Lung Cancer"},{"key":"655_CR39","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/srep07336","volume":"4","author":"Y Wang","year":"2014","unstructured":"Wang Y, Thomas A, Lau C, Rajan A, Zhu Y, Killian JK, Petrini I, Pham T, Morrow B, Zhong X, et al. Mutations of epigenetic regulatory genes are common in thymic carcinomas. Sci Rep. 2014;4:7336.","journal-title":"Sci Rep"},{"key":"655_CR40","first-page":"316","volume":"3","author":"B Huang","year":"2013","unstructured":"Huang B, Belharazem D, Li L, Kneitz S, Schnabel PA, Rieker RJ, Korner D, Nix W, Schalke B, Muller-Hermelink HK, et al. Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas - Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c. Front Oncol. 2013;3:316.","journal-title":"Front Oncol"},{"key":"655_CR41","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.3016","volume":"46","author":"I Petrini","year":"2014","unstructured":"Petrini I, Meltzer PS, Kim IK, Lucchi M, Park KS, Fontanini G, Gao J, Zucali PA, Calabrese F, Favaretto A, et al. A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. Nat Genet. 2014;46:844\u20139.","journal-title":"Nat Genet"},{"key":"655_CR42","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1038\/cddis.2012.92","volume":"3","author":"I Petrini","year":"2012","unstructured":"Petrini I, Meltzer PS, Zucali PA, Luo J, Lee C, Santoro A, Lee HS, Killian KJ, Wang Y, Tsokos M, et al. Copy number aberrations of BCL2 and CDKN2A\/B identified by array-CGH in thymic epithelial tumors. Cell Death Dis. 2012;3:e351.","journal-title":"Cell Death Dis"},{"key":"655_CR43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.lungcan.2014.04.008","volume":"85","author":"F Ganci","year":"2014","unstructured":"Ganci F, Vico C, Korita E, Sacconi A, Gallo E, Mori F, Cambria A, Russo E, Anile M, Vitolo D, et al. MicroRNA expression profiling of thymic epithelial tumors. Lung Cancer. 2014;85:197\u2013204.","journal-title":"Lung Cancer"},{"key":"655_CR44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/bjc.2015.425","volume":"114","author":"M Radovich","year":"2016","unstructured":"Radovich M, Solzak JP, Hancock BA, Conces ML, Atale R, Porter RF, Zhu J, Glasscock J, Kesler KA, Badve SS, et al. A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas. Br J Cancer. 2016;114:477\u201384.","journal-title":"Br J Cancer"},{"key":"655_CR45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/15384047.2015.1108493","volume":"17","author":"T Bellissimo","year":"2016","unstructured":"Bellissimo T, Russo E, Ganci F, Vico C, Sacconi A, Longo F, Vitolo D, Anile M, Disio D, Marino M, et al. Circulating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumors. Cancer Biol Ther. 2016;17:79\u201382.","journal-title":"Cancer Biol Ther"},{"key":"655_CR46","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.febslet.2014.03.033","volume":"588","author":"G Blandino","year":"2014","unstructured":"Blandino G, Fazi F, Donzelli S, Kedmi M, Sas-Chen A, Muti P, Strano S, Yarden Y. Tumor suppressor microRNAs: a novel non-coding alliance against cancer. FEBS Lett. 2014;588:2639\u201352.","journal-title":"FEBS Lett"},{"key":"655_CR47","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1038\/onc.2010.386","volume":"29","author":"M Gotte","year":"2010","unstructured":"Gotte M, Mohr C, Koo CY, Stock C, Vaske AK, Viola M, Ibrahim SA, Peddibhotla S, Teng YH, Low JY, et al. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene. 2010;29:6569\u201380.","journal-title":"Oncogene"},{"key":"655_CR48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/onc.2012.61","volume":"32","author":"P Gao","year":"2013","unstructured":"Gao P, Xing AY, Zhou GY, Zhang TG, Zhang JP, Gao C, Li H, Shi DB. The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene. 2013;32:491\u2013501.","journal-title":"Oncogene"},{"key":"655_CR49","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/jcmm.12358","volume":"18","author":"SY Cui","year":"2014","unstructured":"Cui SY, Wang R, Chen LB. MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. J Cell Mol Med. 2014;18:1913\u201326.","journal-title":"J Cell Mol Med"},{"key":"655_CR50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/jhg.2013.121","volume":"59","author":"S Kojima","year":"2014","unstructured":"Kojima S, Enokida H, Yoshino H, Itesako T, Chiyomaru T, Kinoshita T, Fuse M, Nishikawa R, Goto Y, Naya Y, et al. The tumor-suppressive microRNA-143\/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer. J Hum Genet. 2014;59:78\u201387.","journal-title":"J Hum Genet"},{"key":"655_CR51","doi-asserted-by":"crossref","first-page":"35183","DOI":"10.18632\/oncotarget.5930","volume":"6","author":"S Donzelli","year":"2015","unstructured":"Donzelli S, Mori F, Bellissimo T, Sacconi A, Casini B, Frixa T, Roscilli G, Aurisicchio L, Facciolo F, Pompili A, et al. Epigenetic silencing of miR-145-5p contributes to brain metastasis. Oncotarget. 2015;6:35183\u2013201.","journal-title":"Oncotarget"},{"key":"655_CR52","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/onc.2013.476","volume":"33","author":"M Cioce","year":"2014","unstructured":"Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, Korita E, Casini B, Alessandrini G, Cambria A, et al. Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma. Oncogene. 2014;33:5319\u201331.","journal-title":"Oncogene"},{"key":"655_CR53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1467-9868.00346","volume":"64","author":"JD Storey","year":"2002","unstructured":"Storey JD. A direct approach to false discovery rates. J R Statist Soc B. 2002;64:479\u201398.","journal-title":"J R Statist Soc B"},{"key":"655_CR54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"655_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W Huang da","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1\u201313.","journal-title":"Nucleic Acids Res"},{"key":"655_CR56","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/ijc.23335","volume":"122","author":"V Ehemann","year":"2008","unstructured":"Ehemann V, Kern MA, Breinig M, Schnabel PA, Gunawan B, Schulten HJ, Schlaeger C, Radlwimmer B, Steger CM, Dienemann H, et al. Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma. Int J Cancer. 2008;122:2719\u201325.","journal-title":"Int J Cancer"},{"key":"655_CR57","doi-asserted-by":"crossref","first-page":"e926","DOI":"10.1038\/cddis.2013.452","volume":"4","author":"I Iosue","year":"2013","unstructured":"Iosue I, Quaranta R, Masciarelli S, Fontemaggi G, Batassa EM, Bertolami C, Ottone T, Divona M, Salvatori B, Padula F, et al. Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells. Cell Death Dis. 2013;4:e926.","journal-title":"Cell Death Dis"},{"key":"655_CR58","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1073\/pnas.89.8.3209","volume":"89","author":"I Screpanti","year":"1992","unstructured":"Screpanti I, Meco D, Scarpa S, Morrone S, Frati L, Gulino A, Modesti A. Neuromodulatory loop mediated by nerve growth factor and interleukin 6 in thymic stromal cell cultures. Proc Natl Acad Sci U S A. 1992;89:3209\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"655_CR59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13148-015-0157-2","volume":"7","author":"C Nervi","year":"2015","unstructured":"Nervi C, De Marinis E, Codacci-Pisanelli G. Epigenetic treatment of solid tumours: a review of clinical trials. Clin Epigenetics. 2015;7:127.","journal-title":"Clin Epigenetics"},{"key":"655_CR60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","volume":"6","author":"S Minucci","year":"2006","unstructured":"Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer. 2006;6:38\u201351.","journal-title":"Nat Rev Cancer"},{"key":"655_CR61","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","volume":"13","author":"KJ Falkenberg","year":"2014","unstructured":"Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov. 2014;13:673\u201391.","journal-title":"Nat Rev Drug Discov"},{"key":"655_CR62","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/2159-8290.CD-11-0214","volume":"1","author":"RA Juergens","year":"2011","unstructured":"Juergens RA, Wrangle J, Vendetti FP, Murphy SC, Zhao M, Coleman B, Sebree R, Rodgers K, Hooker CM, Franco N, et al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov. 2011;1:598\u2013607.","journal-title":"Cancer Discov"},{"key":"655_CR63","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","volume":"15","author":"PJ Loehrer Sr","year":"1997","unstructured":"Loehrer Sr PJ, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, Johnson D. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol. 1997;15:3093\u20139.","journal-title":"J Clin Oncol"},{"key":"655_CR64","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/annonc\/mdn388","volume":"19","author":"C Christodoulou","year":"2008","unstructured":"Christodoulou C, Murray S, Dahabreh J, Petraki K, Nikolakopoulou A, Mavri A, Skarlos D. Response of malignant thymoma to erlotinib. Ann Oncol. 2008;19:1361\u20132.","journal-title":"Ann Oncol"},{"key":"655_CR65","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2741\/2098","volume":"12","author":"G Palmieri","year":"2007","unstructured":"Palmieri G, Marino M, Salvatore M, Budillon A, Meo G, Caraglia M, Montella L. Cetuximab is an active treatment of metastatic and chemorefractory thymoma. Front Biosci. 2007;12:757\u201361.","journal-title":"Front Biosci"},{"key":"655_CR66","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1470-2045(07)70141-9","volume":"8","author":"G Farina","year":"2007","unstructured":"Farina G, Garassino MC, Gambacorta M, La Verde N, Gherardi G, Scanni A. Response of thymoma to cetuximab. Lancet Oncol. 2007;8:449\u201350.","journal-title":"Lancet Oncol"},{"key":"655_CR67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4161\/rna.8.1.14259","volume":"8","author":"WC Cho","year":"2011","unstructured":"Cho WC, Chow AS, Au JS. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol. 2011;8:125\u201331.","journal-title":"RNA Biol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-017-0655-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T21:48:15Z","timestamp":1589752095000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-017-0655-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,10]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["655"],"URL":"https:\/\/doi.org\/10.1186\/s12943-017-0655-2","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,10]]},"article-number":"88"}}